| Literature DB >> 32536603 |
Steven T Bruckbauer1, Benjamin B Minkoff2, Deyang Yu3, Vincent L Cryns3, Michael M Cox4, Michael R Sussman5.
Abstract
Recent work has begun to investigate the role of protein damage in cell death because of ionizing radiation (IR) exposure, but none have been performed on a proteome-wide basis, nor have they utilized MS (MS) to determine chemical identity of the amino acid side chain alteration. Here, we use Escherichia coli to perform the first MS analysis of IR-treated intact cells on a proteome scale. From quintuplicate IR-treated (1000 Gy) and untreated replicates, we successfully quantified 13,262 peptides mapping to 1938 unique proteins. Statistically significant, but low in magnitude (<2-fold), IR-induced changes in peptide abundance were observed in 12% of all peptides detected, although oxidative alterations were rare. Hydroxylation (+15.99 Da) was the most prevalent covalent adduct detected. In parallel with these studies on E. coli, identical experiments with the IR-resistant bacterium, Deinococcus radiodurans, revealed orders of magnitude less effect of IR on the proteome. In E. coli, the most significant target of IR by a wide margin was glyceraldehyde 3'-phosphate dehydrogenase (GAPDH), in which the thiol side chain of the catalytic Cys residue was oxidized to sulfonic acid. The same modification was detected in IR-treated human breast carcinoma cells. Sensitivity of GAPDH to reactive oxygen species (ROS) has been described previously in microbes and here, we present GAPDH as an immediate, primary target of IR-induced oxidation across all domains of life.Entities:
Keywords: Tandem mass spectrometry; bacteria; glyceraldehyde-3-phosphate dehydrogenase; ionizing radiation; omics; oxidative stress; protein oxidation; proteome; quantification
Year: 2020 PMID: 32536603 PMCID: PMC8015010 DOI: 10.1074/mcp.RA120.002092
Source DB: PubMed Journal: Mol Cell Proteomics ISSN: 1535-9476 Impact factor: 5.911
Numbers of detected and quantified peptides in irradiated and unirradiated samples of Escherichia coli determined by mass spectrometry
| Total detected | Total quantified | No fold change (irradiated/control) | Fold increase >1 (irradiated/control) | Fold increase >2 (irradiated/control) | Fold decrease <1 (irradiated/control) | Fold decrease <0.5 (irradiated/control) | |
|---|---|---|---|---|---|---|---|
| Total peptides | 15108 | 13262 | 11703 | 764 | 48 | 795 | 2 |
| Carbonylated peptides (+13.979 Da) | 117 | 80 | 72 | 5 | 0 | 3 | 0 |
| Hydroxylated peptides (+15.99 Da) | 1861 | 1664 | 1437 | 175 | 19 | 52 | 0 |
| Dioxidized peptides (+31.99 Da) | 351 | 285 | 247 | 24 | 2 | 14 | 0 |
| Trioxidized peptides (+47.985 Da) | 55 | 41 | 28 | 11 | 2 | 2 | 0 |
| Percent carbonylated | 0.8% | 0.6% | 0.6% | 0.7% | 0.0% | 0.4% | 0.0% |
| Percent hydroxylated | 12.3% | 12.5% | 12.3% | 22.9% | 39.6% | 6.5% | 0.0% |
| Percent dioxidized | 2.3% | 2.1% | 2.1% | 3.1% | 4.2% | 1.8% | 0.0% |
| Percent trioxidized | 0.4% | 0.3% | 0.2% | 1.4% | 4.2% | 0.3% | 0.0% |
*Significance of fold changes in abundance were determined with a threshold of Benjamini-Hochberg adj. p-value < 0.05.
Numbers of detected and quantified peptides in irradiated and unirradiated samples of Deinococcus radiodurans determined by mass spectrometry
| Total detected | Total quantified | No fold change (irradiated/control) | Fold increase >1 (irradiated/control) | Fold increase >2 (irradiated/control) | Fold decrease <1 (irradiated/control) | Fold decrease <0.5 (irradiated/control) | |
|---|---|---|---|---|---|---|---|
| Total peptides | 13777 | 11526 | 11525 | 1 | 1 | 0 | 0 |
| Carbonylated peptides (+13.979 Da) | 189 | 134 | 134 | 0 | 0 | 0 | 0 |
| Oxidized peptides (+15.99 Da) | 2198 | 1779 | 1778 | 1 | 1 | 0 | 0 |
| Dioxidized peptides (+31.99 Da) | 498 | 399 | 399 | 0 | 0 | 0 | 0 |
| Trioxidized peptides (+47.985 Da) | 43 | 26 | 26 | 0 | 0 | 0 | 0 |
| Percent carbonylated | 1.4% | 1.2% | 1.2% | 0.0% | 0.0% | N/A | N/A |
| Percent hydroxylated | 16.0% | 15.4% | 15.4% | 100.0% | 100.0% | N/A | N/A |
| Percent dioxidized | 3.6% | 3.5% | 3.5% | 0.0% | 0.0% | N/A | N/A |
| Percent trioxidized | 0.3% | 0.2% | 0.2% | 0.0% | 0.0% | N/A | N/A |
*Significance of fold changes in abundance were determined with a threshold of Benjamini-Hochberg adj. p-value < 0.05.
Amino acid modifications on peptides with significant increases in abundance because of IR treatment
| Residue | Carbonylation (+13.979 Da) | Hydroxylation (+15.99 Da) | Dioxidation (+31.99 Da) | Trioxidation (+47.985 Da) |
|---|---|---|---|---|
| A | 2 | N/A | N/A | N/A |
| C | N/A | 0 | 0 | 8 |
| D | N/A | 1 | N/A | N/A |
| E | 1 | 1 | 0 | N/A |
| F | N/A | 4 | 0 | 0 |
| G | N/A | N/A | N/A | N/A |
| H | N/A | 1 | N/A | N/A |
| I | 1 | 1 | 0 | N/A |
| K | N/A | 0 | N/A | N/A |
| L | 2 | 6 | 0 | N/A |
| M | N/A | 137 | 0 | N/A |
| N | N/A | 0 | N/A | N/A |
| P | N/A | 0 | N/A | N/A |
| Q | 0 | 0 | N/A | N/A |
| R | 0 | 0 | 0 | N/A |
| S | 0 | 3 | N/A | N/A |
| T | N/A | 0 | N/A | N/A |
| V | 2 | 1 | 0 | N/A |
| W | N/A | 6 | 20 | 3 |
| Y | N/A | 4 | 2 | 0 |
| Total | 8 | 165 | 22 | 11 |
*N/A indicates that the residue was not searched for that modification, as detailed in Methods.
Fig. 1Increase in abundance of oxidized peptides because of IR exposure.A, Of the nearly 13,996 quantified peptides (indicated by each circle) in E. coli cells, approximately 12% have statistically significant (fold change greater or less than 1, Benjamini-Hochberg adj. p-value < 0.05) changes in abundance because of 1000 Gy of irradiation. B, When D. radiodurans is irradiated with 1000 Gy under identical conditions as E. coli, there is only one peptide out of the 11,715 that shows a significant fold change in abundance. C, When the E. coli data set is randomized across the ten channels (five without treatment, five with), and fold changes are recalculated, there are no statistically significant changes observed. The spread of fold changes with low significance closely resembles the D. radiodurans data set.
Fig. 2Proteins with greater molecular weight and abundance are more prone to IR-induced hydroxylation.A, Relative absolute mass (RAM) values of proteins detected. A RAM value was calculated using abundance and molecular weight values from E. coli grown in medium with glycerol as the sole carbon source, as previously reported (40). RAM was used as a rough predictor of target size of each protein in E. coli. The distribution RAM values for all proteins detected in the Schmidt et al. study (40) are pictured in light gray, and those that were detected in this study are pictured in dark gray. The distribution of RAM values for all proteins mapped from peptides with significant fold changes (fold change in abundance >1 or <1, Benjamini-Hochberg adj. p-value <0.05.) is pictured in light blue, and the hydroxylated peptides with the same significance criteria is pictured in dark blue. The distribution of RAM values for all proteins mapped from peptides with fold changes in abundance >2 or <0.5 (Benjamini-Hochberg adj. p-value <0.05.) is pictured in orange, and the hydroxylated peptides with the same significance criteria is pictured in red. “n” values indicate the number of proteins that fall into each category. The “*” symbol indicates that the distributions are significantly different with an adjusted p-value > 1 × 10−5 as calculated by a 2-tailed Student's t test. B, Separated molecular weight and abundance values of proteins detected. Each protein detected was graphed as circle based on the molecular weight and abundance values utilized to calculate the RAM metric (40). Glyceraldehyde 3′-phosphate dehydrogenase (GAPDH; encoded by gapA) and elongation factor Tu (Ef-Tu; encoded by tufA) are indicated.
Hydroxylated peptides with significantly increased abundance because of IR exposure in E. coli
| Protein | Master protein descriptions | Protein accession | Relative protein abundance | Peptide sequence | Modifications | Fold change (treated: untreated) | Adjusted | Manual validati on of oxidative modification |
|---|---|---|---|---|---|---|---|---|
| GapA | Glyceraldehyde-3-phosphate dehydrogenase A | P0A9B2 | 0.170 | [K].YAGQDIVSNAS | 1xTrioxidation [C12]; 1 ×TMT6plex [K22]; 1 ×TMT6plex [N-Term]; 1 ×Carbamidomethyl [C16] | 20.12 | 0.005 | OK |
| TalB | Transaldolase B | P0A870 | 0.059 | [R].LTIAPAL | 1xHydroxylation [L8]; 1 ×TMT6plex [K9]; 1 ×TMT6plex [N-Term] | 3.16 | 0.008 | OK |
| Pal | Peptidoglycan-associated lipoprotein | P0A912 | 0.085 | [K]. | 1xHydroxylation [M1]; 1 ×TMT6plex [K6]; 1 ×TMT6plex [N-Term] | 5.35 | 0.043 | OK |
| [R].S.D.FAQ | 1xHydroxylation [M6]; 1 ×TMT6plex [N-Term] | 2.41 | 0.038 | OK | ||||
| LptE | LPS-assembly lipoprotein | P0ADC1 | 0.001 | [R].SFFDNPQ | 1xHydroxylation [M8]; 1 ×TMT6plex [K12]; 1 ×TMT6plex [N-Term] | 2.98 | 0.003 | OK |
| HtpG | Chaperone protein | P0A6Z3 | 0.010 | [R].LTDTPAIVSTDADE | 2xHydroxylation [M15; M19]; 1 ×TMT6plex [K21]; 1 ×TMT6plex [N-Term] | 2.10 | 0.009 | OK |
| RplB | 50S ribosomal protein L2 | P60422 | 0.064 | [K].HPVTPWGVQTK.[G] | 1xHydroxylation [P/W]; 1 ×TMT6plex [K11]; 1 ×TMT6plex [N-Term] | 2.77 | 0.022 | Ambiguous, likely W6 |
| RpmB | 50S ribosomal protein L28 | P0A7M2 | 0.032 | [R].F | 1xTrioxidation [W2]; 1 ×TMT6plex [K7]; 1 ×TMT6plex [N-Term] | 2.22 | 0.049 | OK |
| RpsD | 30S ribosomal protein S4 | P0A7V8 | 0.070 | [R]. | 1xHydroxylation [M1]; 1 ×TMT6plex [N-Term] | 2.03 | 0.049 | OK |
| RpsN | 30S ribosomal protein S14 | P0AG59 | 0.040 | [R].EAA | 1xHydroxylation [M4]; 1 ×TMT6plex [K12]; 1 ×TMT6plex [N-Term] | 2.85 | 0.007 | OK |
| [K].AIISDVNASDEDR | 1xDioxidation [W14]; 1 ×TMT6plex [K19]; 1 ×TMT6plex [N-Term] | 2.40 | 0.035 | OK | ||||
| FusA | Elongation factor G | P0A6M8 | 0.163 | [K].IATDP | 1xHydroxylation [F6]; 1 ×TMT6plex [N-Term] | 3.33 | 0.005 | OK |
| TufA | Elongation factor Tu | P0CE47 | 1.000 | [R].A | 1xHydroxylation [F2]; 1 ×TMT6plex [K12]; 1 ×TMT6plex [N-Term] | 6.30 | 0.005 | OK |
| [K].VGEEVEIVG | 1xHydroxylation [I10]; 1 ×TMT6plex [K11]; 1 ×TMT6plex [N-Term] | 5.46 | 0.008 | OK | ||||
| [R].AGENVGV | 1xHydroxylation [L8]; 1 ×TMT6plex [N-Term] | 4.17 | 0.004 | OK | ||||
| [K].STCTGVEMFR.[K] | 1xDioxidation [E7]; 2 ×Hydroxylation [M8; F9]; 1 ×TMT6plex [N-Term]; 1 ×Carbamidomethyl [C3] | 3.82 | 0.004 | Ambiguous, likely either dioxidation on E7, or dioxidation on M8, or single hydroxylation on M8 and F9 | ||||
| [R]. | 1xHydroxylation [H1]; 1 ×TMT6plex [K6]; 1 ×TMT6plex [N-Term] | 3.60 | 0.001 | OK | ||||
| [K]. | 1xHydroxylation [L1]; 1 ×TMT6plex [N-Term] | 3.34 | 0.006 | OK | ||||
| [R].QVGVPYIIVF | 1xHydroxylation [L11]; 1 ×TMT6plex [K13]; 1 ×TMT6plex [N-Term] | 2.78 | 0.016 | OK | ||||
| [R].TVGAGV | 1xHydroxylation [V7]; 1 ×TMT6plex [K9]; 1 ×TMT6plex [N-Term] | 2.10 | 0.023 | OK | ||||
| [K].TTLTAAITTVLAK.[T] | 1xHydroxylation [I/L]; 1 ×TMT6plex [K13]; 1 ×TMT6plex [N-Term] | 2.05 | 0.019 | Ambiguous | ||||
| YgfK | Putative oxidoreductase | Q46811 | N/A | [K].S | 2xHydroxylation [L2; F4]; 1 ×TMT6plex [K7]; 1 ×TMT6plex [N-Term] | 2.34 | 0.027 | OK |
*Peptides listed are those with a significant fold increase (fold change >2, Benjamini- Hochberg adj. p-value <0.05.) and have at least one modification. If the oxidative modification was localized to a residue, the residue number in the peptide is listed and the residue is underlined. If our analysis could not determine which residue was modified, the candidate residues are separated by “/” symbols. Each oxidative modification was additionally assessed by manual inspection of mass spectra, as indicated by the far-right column. Protein accession numbers are from UniProt (85). Relative abundance values are based on previously reported values (40) and are those used for RAM analysis; being the most abundant E. coli protein, EF-Tu is set to “1.” YgfK abundance was not previously quantified, and therefore does not have a relative abundance value.
Fig. 3Mass spectra of A, Example fragment ion spectra of (A) nonoxidized and B, sulfonic acid-modified active site cysteine of E. coli GAPDH. Sequence and fragment ion diagram correspond to annotated spectra and identified ions in the y- and b- series are underlined in respective colors.
All GAPDH peptides quantified in this study
| Protein | Peptide sequence | Modifications | Fold change (treated:untreated) | Adjusted | Manual localization of oxidative modification |
|---|---|---|---|---|---|
| [K].YAGQDIVSNASCTTNCLAPLAK.[V] | 1xCarbamidomethyl [C16]; 1 ×Trioxidation [C12]; 1 ×TMT6plex [K22]; 1 ×TMT6plex [N-Term] | 20.12 | 5.1E-03 | OK | |
| [K].AGIALNDNFVK.[L] | 1xTMT6plex [K11]; 1 ×TMT6plex [N-Term] | 2.02 | 4.7E-03 | N/A | |
| [K].LTGMAFR.[V] | 1xOxidation [M4]; 1 ×TMT6plex [N-Term] | 1.97 | 4.1E-03 | OK | |
| [K].DNTPMFVK.[G] | 1xTMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.92 | 7.3E-03 | N/A | |
| [K].LTGMAFR.[V] | 1xTMT6plex [N-Term] | 1.90 | 3.9E-03 | N/A | |
| [K].DNTPMFVK.[G] | 1xOxidation [M5]; 1 ×TMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.88 | 5.8E-03 | OK | |
| [R].GASQNIIPSSTGAAK.[A] | 1xTMT6plex [K15]; 1 ×TMT6plex [N-Term] | 1.86 | 9.5E-03 | N/A | |
| [R].FDGTVEVK.[D] | 1xTMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.86 | 1.9E-02 | N/A | |
| [K].LVSWYDNETGYSNK.[V] | 1xTMT6plex [K14]; 1 ×TMT6plex [N-Term] | 1.83 | 6.6E-03 | N/A | |
| [K].VGINGFGR.[I] | 1xTMT6plex [N-Term] | 1.79 | 9.1E-03 | N/A | |
| [K].VLPELNGK.[L] | 1xTMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.71 | 6.6E-03 | N/A | |
| [R].VPTPNVSVVDLTVR.[L] | 1xTMT6plex [N-Term] | 1.52 | 5.7E-03 | N/A | |
| [K].AATYEQIK.[A] | 1xTMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.52 | 2.2E-02 | N/A | |
| [K].VVMTGPSK.[D] | 1xTMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.49 | 2.7E-02 | N/A | |
| [R].VPTPNVSVVDLTVRLEK.[A] | 1xTMT6plex [K17]; 1 ×TMT6plex [N-Term] | 1.43 | 2.8E-01 | N/A | |
| [K].VVMTGPSK.[D] | 1xOxidation [M3]; 1 ×TMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.39 | 2.5E-02 | OK | |
| [K].AAAEGEMK.[G] | 1xOxidation [M7]; 1 ×TMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.33 | 1.4E-01 | OK | |
| [R].VTAERDPANLK.[W] | 1xTMT6plex [K11]; 1 ×TMT6plex [N-Term] | 1.32 | 1.8E-01 | N/A | |
| [K].GANFDK.[Y] | 1xTMT6plex [K6]; 1 ×TMT6plex [N-Term] | 1.30 | 2.4E-01 | N/A | |
| [K].VLDLIAHISK.[-] | 1xTMT6plex [K10]; 1 ×TMT6plex [N-Term] | 1.28 | 1.4E-01 | N/A | |
| [K].AAAEGEMK.[G] | 1xTMT6plex [K8]; 1 ×TMT6plex [N-Term] | 1.21 | 7.9E-02 | N/A | |
| [K].YAGQDIVSNASCTTNCLAPLAK.[V] | 2xCarbamidomethyl [C12; C16]; 1 ×TMT6plex [K22]; 1 ×TMT6plex [N-Term] | 1.12 | 3.6E-01 | N/A | |
| [K].YAGQDIVSNASCTTNCLAPLAK.[V] | 2xCarbamidomethyl [C12; C16]; 1 ×Oxidation [T13]; 1 ×TMT6plex [K22]; 1 ×TMT6plex [N-Term] | 1.06 | 6.5E-01 | Ambiguous between T13/T14 | |
| [K].DGHLIVNGK.[K] | 1xTMT6plex [K9]; 1 ×TMT6plex [N-Term] | 1.03 | 9.3E-01 | N/A | |
| [K].TVDGPSHK.[D] | 1xTMT6plex [K8]; 1 ×TMT6plex [N-Term] | 0.90 | 7.8E-01 | N/A | |
| [R].GVEVVAINDLTDNHTLAHLLK.[Y] | 1xTMT6plex [K21]; 1 ×TMT6plex [N-Term] | 1.21 | 1.7E + 00 | N/A | |
| [K].KVIITAPAK.[G] | 2xTMT6plex [K1; K9]; 1 ×TMT6plex [N-Term] | 1.19 | 1.1E + 00 | N/A | |
| [R].VLDLPHSDLRR.[A] | 1xTMT6plex [N-Term] | 1.11 | 1.2E + 00 | N/A | |
| [R].IADLVQLVQNK.[G] | 1xTMT6plex [K11]; 1 ×TMT6plex [N-Term] | 1.10 | 1.1E + 00 | N/A | |
| [K].VIDEAFGIEK.[A] | 1xTMT6plex [K10]; 1 ×TMT6plex [N-Term] | 1.09 | 1.3E + 00 | N/A | |
| [R].AAAINIIPTSTGAAK.[A] | 1xTMT6plex [K15]; 1 ×TMT6plex [N-Term] | 1.08 | 1.5E + 00 | N/A | |
| [R].VPTPTGSISDVSVILGR.[D] | 1xTMT6plex [N-Term] | 1.07 | 1.2E + 00 | N/A | |
| [R].VLDLPHSDLR.[R] | 1xTMT6plex [N-Term] | 1.07 | 1.3E + 00 | N/A | |
| [K].AIMTTVHSYTNDQR.[V] | 1xTMT6plex [N-Term] | 1.07 | 1.0E + 00 | N/A | |
| [K].AVSQVYPALK.[G] | 1xOxidation [Y6]; 1 ×TMT6plex [K10]; 1 ×TMT6plex [N-Term] | 1.07 | 1.2E + 00 | OK | |
| [K].AVSQVYPALK.[G] | 1xOxidation [Y6]; 1 ×Carbonyl [V5]; 1 ×TMT6plex [K10]; 1 ×TMT6plex [N-Term] | 1.06 | 1.0E + 00 | OK | |
| [K].AIMTTVHSYTNDQR.[V] | 2xOxidation [M3; N/I]; 1 ×TMT6plex [N-Term] | 1.04 | 1.0E + 00 | Yes M3, Ambiguous on second between Y9-N11 | |
| [K].IQAIAERDPANIK.[W] | 1xTMT6plex [K13]; 1 ×TMT6plex [N-Term] | 1.02 | 1.0E + 00 | N/A | |
| [R].DVTVEEVNNVFR.[E] | 1xTMT6plex [N-Term] | 1.02 | 1.0E + 00 | N/A | |
| [K].AVSQVYPALK.[G] | 1xTMT6plex [K10]; 1 ×TMT6plex [N-Term] | 1.01 | 1.0E + 00 | N/A | |
| [K].AVSQVYPALK.[G] | 1xDioxidation [Y/P]; 1 ×TMT6plex [K10]; 1 ×TMT6plex [N-Term] | 0.99 | 1.0E + 00 | Ambiguous, almost certainly on Y6 | |
| [R].FDGTVEYDESSLTVNGK.[K] | 1xTMT6plex [K17]; 1 ×TMT6plex [N-Term] | 0.95 | 1.0E + 00 | N/A | |
| [K].AIMTTVHSYTNDQR.[V] | 1xOxidation [T/V/M]; 1 ×TMT6plex [N-Term] | 0.92 | 1.1E + 00 | Ambiguous, almost certainly on M3 | |
| [K].FDGTSLR.[V] | 1xTMT6plex [N-Term] | 0.90 | 1.0E + 00 | N/A | |
| [K].VIITAPAK.[G] | 1xTMT6plex [K8]; 1 ×TMT6plex [N-Term] | 0.89 | 1.3E + 00 | N/A | |
| [K].IQAIAER.[D] | 1xTMT6plex [N-Term] | 0.87 | 1.2E + 00 | N/A | |
| [R].VPTANVSVVDLTCR.[L] | 2.116 | 1.41E-04 | N/A | ||
| [K].VIHDNFGIVEGLMTTVHAITATQK.[T] | 1xOxidation [M/T/L] | 1.694 | 1.39E-03 | Ambiguous, almost certainly on M13 | |
| [R].VVDLMAHMASK.[E] | 1.464 | 1.15E-02 | N/A | ||
| [R].VPTANVSVVDLTCR.[L] | 1xCarbamidomethyl [C13] | 1.452 | 5.22E-03 | N/A | |
| [R].VVDLMAHMASKE.[-] | 1.405 | 3.38E-02 | N/A | ||
| [K].LISWYDNEFGYSNR.[V] | 1xDioxidation [W/Y]; 2 ×Oxidation [W4; Y5] | 1.271 | 2.54E-01 | Ambiguous, almost certainly Dioxidation on W4 | |
| [K].LTGMAFR.[V] | 1.259 | 1.88E-01 | N/A | ||
| [K].LVINGNPITIFQERDPSK.[I] | 1.176 | 6.23E-01 | N/A | ||
| [K].VGVNGFGR.[I] | 1.161 | 5.83E-01 | N/A | ||
| [R].VIISAPSADAPMFVMGVNHEK.[Y] | 1.158 | 5.95E-01 | N/A | ||
| [R].VVDLMAHMASKE.[-] | 1xOxidation [L/H/M] | 1.126 | 9.27E-01 | Ambiguous, almost certainly on M5 | |
| [K].IISNASCTTNCLAPLAK.[V] | 2xCarbamidomethyl [C7; C11] | 1.122 | 7.72E-01 | N/A | |
| [K].VIPELNGK.[L] | 1.107 | 8.35E-01 | N/A | ||
| [K].RVIISAPSADAPMFVMGVNHEK.[Y] | 1.069 | 9.89E-01 | N/A | ||
| [R].GALQNIIPASTGAAK.[A] | 1.021 | 1.00E + 00 | N/A | ||
| [K].LVINGNPITIFQER.[D] | 0.98 | 1.00E + 00 | N/A | ||
| [R].VVDLMAHMASK.[E] | 1xOxidation [M/H] | 0.961 | 1.00E + 00 | Ambiguous, almost certainly on M5 | |
| [K].LISWYDNEFGYSNR.[V] | 1xCarbonyl [E8] | 0.935 | 9.89E-01 | OK | |
| [K].LISWYDNEFGYSNR.[V] | 1xOxidation [W4] | 0.882 | 9.28E-01 | OK | |
| [K].WGDAGAEYVVESTGVFTTMEK.[A] | 1xCarbonyl [E7] | 0.879 | 9.45E-01 | OK | |
| [K].AGAHLQGGAK.[R] | 0.865 | 9.27E-01 | N/A | ||
| [R].VIISAPSADAPMFVMGVNHEK.[Y] | 1xDioxidation [F13]; 2 ×Oxidation [M12; M15] | 0.851 | 6.68E-01 | Ambiguous, most likely hydroxylation on both M12/M15 | |
| [K].LISWYDNEFGYSNR.[V] | 0.844 | 6.29E-01 | N/A | ||
| [K].LISWYDNEFGYSNR.[V] | 1xTrioxidation [Y/W] | 0.841 | 9.72E-01 | Ambiguous between W4/Y5 | |
| [K].WGDAGAEYVVESTGVFTTMEK.[A] | 0.811 | 3.95E-01 | N/A | ||
| [K].QASEGPLK.[G] | 0.803 | 3.43E-01 | N/A | ||
| [K].WGDAGAEYVVESTGVFTTMEK.[A] | 1xOxidation [M/Y/E/S] | 0.702 | 2.10E-02 | Ambiguous, almost certainly on M19 | |
| [R].VIISAPSADAPMFVMGVNHEK.[Y] | 1xOxidation [M/F/P] | 0.694 | 1.57E-02 | OK | |
| [K].TVDGPSGK.[L] | 0.617 | 7.53E-03 | N/A | ||
| [K].VIHDNFGIVEGLMTTVHAITATQK.[T] | 0.491 | 1.30E-09 | N/A | ||
| [K].WGDAGAEYVVESTGVFTTMEK.[A] | 1xOxidation [T18]; 1 ×Carbonyl [E7] | 0.491 | 1.77E-01 | Yes E7, Ambiguous hydroxylation on T18 or M19 | |
| [R].VVDLMAHMASK.[E] | 2xOxidation [M5; M8] | 0.474 | 1.14E-04 | OK | |
| [K].GILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVK.[L] | 0.281 | 6.56E-16 | N/A | ||
| [K].IISNASCTTNCLAPLAK.[V] | 1xCarbamidomethyl [C]; 1 ×Dioxidation [C7]; 2 ×Oxidation [S3; S6] | 1000 Gy only | 6.56E-16 | Ambiguous between hydroxylation on S3/S6 and dioxidation on C7 | |
| [K].IISNASCTTNCLAPLAK.[V] | 1xCarbamidomethyl [C11]; 1 ×Trioxidation [C7] | 1000 Gy only | 6.56E-16 | OK | |
*Peptides listed map to the GAPDH protein of each respective organism. Adjusted p-values listed are Benjamini-Hochberg adjusted. Each oxidative modification was assessed by manual inspection of mass spectra, as indicated by the far-right column. Protein accession numbers are from UniProt (85).
Fig. 4Mass spectra of A, Example fragment ion spectra of (A) nonoxidized and B, sulfonic acid-modified active site cysteine of H. sapiens GAPDH from the endothelial breast carcinoma cell line MDA-MB-231. Sequence and fragment ion diagram correspond to annotated spectra and identified ions in the y- and b- series are underlined in respective colors.
Fig. 5Graphical summary of significantly hydroxylated proteins detected in this study. Abbreviations are as follows: ionizing radiation (IR), NADPH (NADPH), glyceraldehyde 3′-phosphate (G3P). Hydroxylation events are indicated by a red starburst. Blue arrows are indicative of enzymatic reactions in glucose and glycerol metabolism. Green arrows indicate the directionality of flux through these pathways in response to hydroxylation of TalB and GapA.
Fig. 6The A, Protein from irradiated and unirradiated whole cells, B, cell lysates, and C, dialyzed lysates were prepared and observed as described in the Materials and methods and as illustrated in supplemental Fig. S5D, Sensitivity of dialyzed cell lysates with added GSH. A physiologically relevant concentration of GSH (GSH), 17 mm, (75) was added to dialyzed cell lysates before irradiation as described in the Materials and Methods section.